In case of rs121913300 RB1 polymorphism, ∼20.48-fold increased risk of brain tumor was associated with homozygous mutant genotype (OR, 20.48; 95% CI, 2.72–154.21; P=0.003) in tumor patients. This evidence concerns the gene RB1 and brain neoplasm.